TY - JOUR AU - Sener, Michelle F. AU - Rogozinski, Thaddeus AU - George, James S. AU - Mital, Deepak AU - Slakey, Douglas P. PY - 2023 DA - 2023/01/29 TI - Cytomegalovirus and Kidney Transplantation: An Update JO - OBM Transplantation SP - 174 VL - 07 IS - 01 AB - Cytomegalovirus (CMV) infection is the most common infection affecting kidney transplant recipients [1]. CMV may be present as asymptomatic viremia or with symptoms ranging from mild to significant tissue-invasive disease [1-3]. Optimal kidney graft function and survival requires that transplant care teams carefully assess individual patient risk of CMV [2, 3]. Appropriate patient surveillance and prophylaxis are essential to ensure the best long-term kidney transplant results. Effective treatment of CMV disease requires a high degree of suspicion and appropriate diagnostic tests. The choice of antiviral medication and duration of treatment are important considerations to ensure optimal patient outcomes and kidney graft function and survival. SN - 2577-5820 UR - https://doi.org/10.21926/obm.transplant.2301174 DO - 10.21926/obm.transplant.2301174 ID - Sener2023 ER -